Yayın:
Design, Synthesis, In vitro and In silico Evaluation of New Hydrazonebased Antitumor Agents as Potent Akt Inhibitors

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGüngör, Emine Merve
dc.contributor.authorSEVER, BELGİN
dc.contributor.authorALTINTOP, MEHLİKA DİLEK
dc.contributor.authorÇiftçi, Gülşen Akalın
dc.contributor.orcid0000-0002-8159-663X
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0001-5098-8967
dc.date.accessioned2025-11-13T10:48:31Z
dc.date.issued2020-06-18
dc.identifier.doihttps://doi.org/10.2174/1570180817999200618163507
dc.identifier.endpage1392
dc.identifier.issn1570-1808
dc.identifier.issue11
dc.identifier.openalexW3036663478
dc.identifier.startpage1380
dc.identifier.urihttps://hdl.handle.net/11421/5317
dc.identifier.urihttps://doi.org/10.2174/1570180817999200618163507
dc.identifier.volume17
dc.language.isoen
dc.relation.ispartofLetters in Drug Design & Discovery
dc.rightsrestrictedAccess
dc.subjectProtein kinase B
dc.subjectChemistry
dc.subjectADME
dc.subjectApoptosis
dc.subjectCell culture
dc.subjectIC50
dc.subjectDocking (animal)
dc.subjectPharmacology
dc.subjectIn vitro
dc.subjectIn silico
dc.subjectCancer research
dc.subjectBiochemistry
dc.subjectBiology
dc.subjectMedicine
dc.subject.sdg3
dc.titleDesign, Synthesis, In vitro and In silico Evaluation of New Hydrazonebased Antitumor Agents as Potent Akt Inhibitors
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5025537506
local.authorid.openalexA5040352588
local.authorid.openalexA5048968214
local.authorid.openalexA5045943806

Dosyalar

Koleksiyonlar

Publications